Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Comment by Aquaman11on Feb 09, 2021 4:27pm
211 Views
Post# 32516619

RE:RE:RE:Nice clear message today

RE:RE:RE:Nice clear message today

ICT1111 wrote: Happy with that message from our CEO, I wonder if he has found the original term sheet on Joe's desk .........? I said the solution was there!

Always appreciate your inputs ICT.

Though I always remain cautious (not to say doubtful) since the Restructuring Group had their effort curbed (and even long before that...), I very much appreciate some transparency on the part of the new CEO.  It's still fairly non-specific, but it adresses many of the major points of concern for most of us here. 

Tough the financial aspect has been left out and I'm still very much wondering how he and the BOD's are getting compensated and where the finances are at at this point.

If we still have no details of what will be proposed - and we can surely expect some unreasonable demands from Global/Bakema as history has proven- we'll see how much Rhodes is willing to pull on the shareholder's side as it should be as CEO of Medical.  I am not forgetting that technically, it is the Global people who brought him onboard and one would be in a bad position to bite the hand that feeds him.

So far I do appreciate that he is keeping us abreast of his efforts.

Let's see what comes next.



 

<< Previous
Bullboard Posts
Next >>